NEW YORK, NY April 8th, 2015 – OTCBBJournal Initiates Special Alert and Extended Coverage of Avra, Inc. (OTCQB: AVRN)

We have very high near term expectations for this week’s feature alert.

AVRA, Inc. (OTCQB: AVRN)

The company focuses on solutions in the cryptocurrency and digital currency markets (primarily the “Bitcoin” market) offering payment solutions to businesses worldwide.

•    According to the website www.blockchain.info, the number of daily transactions using Bitcoins has grown over the last two years from approximately 33,000 to approximately 115,000.
•    Merchants are incentivized to accept Bitcoins for payment due to transaction fees that are lower than the 2% to 3% fees that are typically imposed by credit card processors, such as MasterCard® and VISA®.
•    Unlike credit card purchases, transaction fees for purchases made with Bitcoins are paid by the purchaser, rather than the merchant. This has accounted for some of the growth and popularity of bitcoin transactions.
•    Small public float under 27M shares

Companies Releasing Important News to Investors:

Sunshine Biopharma, Inc. (OTCQB: SBFM) is a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer.

The Company's lead anti-cancer compound, Adva-27a, is currently in late stage preclinical studies. Get an update on this product in the full report you can read at this link: http://bit.ly/-SBFM-AnalystUpdate

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies.

The Company entered into an agreement with Woodford Investment Management LLP, as agent for the CF Woodford Equity Income Fund and other clients, for financing of $40 million. Get the details of the financing in this report: http://bit.ly/-NWBO-AnalystUpdate

Northstar Global Business Services, Inc.  (OTCBB: MDIN) is producing alternative healthcare products. The company's products include Snorenz(r), Good Night's Sleep(r), Stem-Intense, and more. Most of the company's products use a unique or patented spray delivery system, and have sold millions of units from 1996 to the present.

The company has a new CEO and new plans to maximize revenues from their products. Read about the innovations in the report located at this link: http://bit.ly/-MDIN-AnalystUpdate

IJJ Corp. (OTCBB: IJJP) is a full service business and management-consulting group promoting the union of companies to achieve their goals. Their focus is on both Public and Private Business professionals to increase resources designed to help organizations succeed through partnerships and growth objectives.

The company has taken steps to ensure that investors have sufficient information regarding their share structure. Get the details in this report: http://bit.ly/-IJJP-AnalystUpdate

About OTCBBJournal
We make the connection between sophisticated investors and high quality small cap companies. An issuer of reports written by chartered financial analysts (CFA’s) who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

For more information and services provided beyond this release please use contact information provided below.

Forward-Looking Disclaimer   
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.   

Compliance Procedure   
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.

A full disclaimer can be found by viewing the analyst report.

If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@otcbbjournal.com. For any urgent concerns or inquiries please contact us at editor@otcbbjournal.com.

Source: OTCBBJournal
Contact: editor@otcbbjournal.com

 
 

MedGen (CE) (USOTC:MDIN)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas MedGen (CE).
MedGen (CE) (USOTC:MDIN)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas MedGen (CE).